BioSpace News Archive

iSpecimen Inc. today reported its financial and operating results for the three- and nine-month period ended September 30, 2022.

SciSparc Ltd. (Nasdaq: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “Company” or “SciSparc”), announced today that the U.S. Patent and Trademark Office has granted it a new patent - U.S. Patent No. 11,491,172, title: COMPOSITIONS AND METHODS OF POTENTIATING ANTIMICROBIALS (the “Patent”).

Compugen Ltd. announced today that Anat Cohen-Dayag , Ph.D., President and CEO, and additional members of its management team will participate in a fireside chat at the upcoming Stifel 2022 Healthcare Conference in New York City.

Fusion Pharmaceuticals Inc. today announced financial results for the third quarter ended September 30, 2022 and provided an update on clinical and corporate developments.

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced financial results for the third quarter ended September 30, 2022 and provided a business update.

ADC Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates.

Exscientia plc (Nasdaq: EXAI) will report financial results for the third quarter ended September 30, 2022, on Tuesday, November 15, 2022, before the open of U.S. markets.

Linear Health Sciences Receives Innovative Technology Contract from Vizient for Orchid SRV IV Safety Device.

IMV Inc. today announced that it will hold a conference call and webcast on Friday, November 11, 2022, at 8:00 a.m. ET to discuss the company’s 2022 third quarter financial and operational results.

Spero Therapeutics, Inc. announced the closing of its previously announced exclusive license agreement with GlaxoSmithKline Intellectual Property Limited for tebipenem HBr, an investigational drug being developed as the potentially first oral carbapenem antibiotic for the treatment of complicated urinary tract infections, including pyelonephritis, caused by certain bacteria.